Merck & Co., Inc. (MRK) vs Oracle Corporation (ORCL)
A side-by-side comparison of Merck & Co., Inc. and Oracle Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MRK is classified in Healthcare; ORCL is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MRK
Merck & Co., Inc.
$131.84HealthcareDelayed quote: Jul 28, 2026, 3:59 PM EDT
ORCL
Oracle Corporation
$119.99TechnologyDelayed quote: Jul 28, 2026, 3:59 PM EDT
Total return — MRK vs ORCL
growth of $100 · dividends reinvested · last 30yMRK +990.2%ORCL +3573.7%ORCL compounded faster
MRK ORCL
MRK vs ORCL: by the numbers
- •ORCL is the larger company ($345.63B vs $325.61B market cap).
- •ORCL trades at the lower trailing earnings multiple (20.57 vs 36.83 P/E), one valuation lens rather than an overall verdict.
- •ORCL converts more revenue to profit (25.37% vs 13.62% net margin).
- •ORCL grew revenue faster over the past five years (10.72% vs 8.60% CAGR).
- •MRK pays the higher dividend yield (2.57% vs 1.67%).
Metrics side by side
Valuation
| Metric | MRK | ORCL |
|---|---|---|
| P/E ratio | 36.83 | 20.57 |
| Forward P/E | 47.09 | 16.01 |
| P/S ratio | 4.93 | 5.19 |
| P/B ratio | 7.05 | 8.22 |
| PEG ratio | 1.81 | 1.26 |
| EV / EBITDA | 15.16 | 16.52 |
| FCF yield | 4.37% | N/A |
Profitability
| Metric | MRK | ORCL |
|---|---|---|
| Gross margin | 75.91% | 65.81% |
| Operating margin | 36.17% | 30.85% |
| Net margin | 13.62% | 25.37% |
| ROE | 19.48% | 40.20% |
| ROIC | 18.27% | 7.99% |
Dividends
| Metric | MRK | ORCL |
|---|---|---|
| Dividend yield | 2.57% | 1.67% |
| Payout ratio | 46.03% | 33.67% |
Growth (annualized)
| Metric | MRK | ORCL |
|---|---|---|
| Revenue CAGR (5Y) | 8.60% | 10.72% |
| EPS CAGR (5Y) | 21.21% | 4.93% |
| FCF CAGR (5Y) | 15.69% | -13.18% |
| Total return CAGR (5Y) | 14.44% | 7.88% |
Frequently asked
- Which has the lower trailing P/E, MRK or ORCL?
- ORCL has the lower trailing P/E: MRK trades at 36.83 and ORCL at 20.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MRK or ORCL?
- Over the past five years, ORCL grew revenue faster — MRK at a 8.60% CAGR versus ORCL at 10.72%.
- Does MRK or ORCL pay a bigger dividend?
- MRK yields 2.57% and ORCL yields 1.67% based on trailing dividends and the latest price.
- Is MRK or ORCL more profitable?
- ORCL runs the higher net margin — MRK at 13.62% versus ORCL at 25.37%.
- How have MRK and ORCL total returns compared?
- Over the past 10 years, MRK delivered 12.27% and ORCL delivered 13.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Merck & P/E ratioOracle P/E ratioMerck & dividend yieldOracle dividend yieldMerck & ROEOracle ROEMerck & operating marginOracle operating marginMerck & revenue growthOracle revenue growthMerck & free cash flowOracle free cash flow
Merck & & Oracle appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.